Stocks and Investing
Stocks and Investing
Tue, September 24, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jason Kolbert Maintained (ANIX) at Strong Buy and Held Target at $10 on, Sep 24th, 2024
Jason Kolbert of EF Hutton, Maintained "Anixa Biosciences, Inc." (ANIX) at Strong Buy and Held Target at $10 on, Sep 24th, 2024.
Jason has made no other calls on ANIX in the last 4 months.
There is 1 other peer that has a rating on ANIX. Out of the 1 peers that are also analyzing ANIX, 0 agree with Jason's Rating of Hold.
This is the rating of the analyst that currently disagrees with Jason
- Yi Chen of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $7 on, Tuesday, September 17th, 2024
Contributing Sources